A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

• Michael C. Keefer ,

  Contributed equally to this work with: Michael C. Keefer, Jill Gilmour

  * E-mail: Michael_Keefer@URMC.Rochester.edu

  Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Jill Gilmour ,

  Contributed equally to this work with: Michael C. Keefer, Jill Gilmour

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Peter Hayes,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Dilbinder Gill,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Jakub Kopycinski,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Hannah Cheeseman,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Michelle Cashin-Cox,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Marloes Naarding,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Lorna Clark,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Natalia Fernandez,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Catherine A. Bunce,

  Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Christine M. Hay,

  Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Sabrina Welsh,

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
• Wendy Komaroff,

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
• Lottie Hachaambwa,

  Affiliation University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Tony Tarragona-Fiol,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Eddy Sayeed,

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
• Devika Zachariah,

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
• James Ackland,

  Affiliation Global BioSolutions, Melbourne, Victoria, Australia

  ⨯
• Kelley Loughran,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Burc Barin,

  Affiliation The EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Emmanuel Cormier,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Josephine H. Cox,

  Affiliation IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom

  ⨯
• Patricia Fast,

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
•  [ ... ],
• Jean-Louis Excler

  Affiliation International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America

  ⨯
• [ view all ]
• [ view less ]